Biopharmaceutical Fermentation Market to Grow with a CAGR of 8.15% through 2028
Expanding biopharmaceutical pipeline and Increasing
investments in research and development are factors driving the global Biopharmaceutical
Fermentation market in the forecast
period 2024-2028.
According to
TechSci Research report, “Biopharmaceutical Fermentation Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”,
the Global Biopharmaceutical Fermentation Market stood at USD 24.82 billion in
2022 and is anticipated to grow with a CAGR of 8.15% in the forecast period,
2024-2028. The Global Biopharmaceutical Fermentation Market is a
dynamic sector within the biopharmaceutical industry, dedicated to the
production of therapeutic proteins, vaccines, and biologic drugs. It is driven
by surging global demand for biopharmaceuticals, supported by continuous
advancements in bioprocessing technology. The market benefits from substantial
investments in research and development, leading to an expanding pipeline of
innovative biopharmaceutical products. Regulatory compliance and support
bolster its growth, ensuring product safety and quality. With a focus on
precision and efficiency, the Biopharmaceutical Fermentation Market plays a
pivotal role in delivering life-saving treatments to patients worldwide, making
it a cornerstone of the healthcare industry.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Biopharmaceutical Fermentation Market.”
One
key driver for the Global Biopharmaceutical Fermentation Market is the
burgeoning demand for biopharmaceutical products. As the world faces
increasingly complex healthcare challenges, there is a growing need for
innovative and targeted therapies, such as monoclonal antibodies, vaccines, and
gene therapies. Biopharmaceutical fermentation is essential for producing these
biologic drugs at a large scale. The rising prevalence of chronic diseases, the
pursuit of personalized medicine, and the ongoing development of biotech
solutions have fueled this demand. Consequently, the market continues to expand
to meet the global healthcare system's need for safe, effective, and
cutting-edge biopharmaceutical treatments.
The Global Biopharmaceutical
Fermentation Market is segmented into Product Type, Application, End User, region
and company.
Based on Product
Type, Downstream products in the biopharmaceutical fermentation market are
experiencing remarkable growth due to their pivotal role in the purification
and isolation of biologically derived drugs. This critical phase involves the
separation and refinement of target molecules, ensuring product purity and
efficacy. As biopharmaceutical research and development expand, driven by the
demand for innovative therapies such as monoclonal antibodies, gene therapies,
and vaccines, the need for efficient downstream processes has surged.
Advancements in chromatography, filtration, and purification technologies are
driving this rapid growth, enhancing product yield, reducing production costs,
and accelerating time-to-market for life-saving biopharmaceuticals. This trend
is expected to continue with the ongoing evolution of biopharmaceutical
manufacturing practices.
Based on region,
The Asia-Pacific region is experiencing rapid growth in the biopharmaceutical
fermentation market due to several key factors. First, it offers a large and
increasingly affluent patient population, driving the demand for
biopharmaceutical products. Second, countries in this region have been
investing heavily in biotechnology infrastructure and research, fostering
innovation and development in the sector. Third, cost-effective manufacturing
processes and skilled labor contribute to competitive advantages, attracting
multinational pharmaceutical companies to establish production facilities in
the region. Additionally, supportive government policies and regulatory reforms
have streamlined market access. As a result, Asia-Pacific has emerged as a
thriving hub for biopharmaceutical fermentation, poised for sustained growth.
Major companies
operating in Global Biopharmaceutical Fermentation Market are:
- Agilent Technologies Inc
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- Sartorius Stedim Biotech GmbH
- Eppendorf Inc
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Nova Biomedical Corporation
- Merck KGaA
- Becton, Dickinson and Company
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The future of
the Biopharmaceutical Fermentation Market is poised for continued growth and
innovation. Advancements in biotechnology, including gene editing and cell
therapy, are expanding the scope of biopharmaceuticals, creating new
opportunities. Moreover, the COVID-19 pandemic has accelerated vaccine
development and manufacturing capabilities, emphasizing the importance of
biopharmaceutical fermentation in pandemic preparedness. Bioprocessing
technologies are becoming more efficient and cost-effective, increasing
accessibility to biopharmaceuticals worldwide. Regulatory agencies are adapting
to accommodate these innovations, facilitating faster approvals. With
increasing global healthcare demands and a focus on personalized medicine, the
Biopharmaceutical Fermentation Market is set to remain a dynamic and vital
component of the pharmaceutical industry.,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Biopharmaceutical
Fermentation Market, 2028- Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028 Segmented By Product Type (Upstream Products,
Downstream Products), By Application (Antibiotics, Recombinant Proteins,
Others), By End User (Biopharmaceutical Industries, Contract Research
Organization, Academic Research Institutes, Others), By
Region, By Competition Forecast & Opportunities, 2018-2028F”,
has evaluated the future growth potential of Global Biopharmaceutical
Fermentation Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Biopharmaceutical
Fermentation Market.
Contact
TechSci
Research LLC
420
Lexington Avenue,
Suite 300,
New York,
United
States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com